Rankings
▼
Calendar
IRWD Q2 2016 Earnings — Ironwood Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
IRWD
Ironwood Pharmaceuticals, Inc.
$603M
Q2 2016 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$54M
Gross Profit
$23M
41.7% margin
Operating Income
-$15M
-28.2% margin
Net Income
-$22M
-39.9% margin
EPS (Diluted)
$-0.15
QoQ Revenue Growth
-17.7%
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$107M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$700M
Total Liabilities
$619M
Stockholders' Equity
$81M
Cash & Equivalents
$277M
← FY 2016
All Quarters
Q3 2016 →
